Підписатись
Motahareh Mahi birjand
Motahareh Mahi birjand
Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran
Підтверджена електронна адреса в bums.ac.ir
Назва
Посилання
Посилання
Рік
Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy
S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ...
Journal of cellular physiology 235 (1), 31-64, 2020
1282020
Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review
M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ...
Expert Opinion on Drug Safety 19 (2), 167-186, 2020
532020
How hypoxia regulate exosomes in ischemic diseases and cancer microenvironment?
S Yaghoubi, H Najminejad, M Dabaghian, MH Karimi, ...
IUBMB life 72 (7), 1286-1305, 2020
352020
Optimizing compliance with surgical antimicrobial prophylaxis guidelines in patients undergoing gastrointestinal surgery at a referral teaching hospital in southern Iran …
L Mahmoudi, M Ghouchani, M Mahi-Birjand, A Bananzadeh, A Akbari
Infection and drug resistance, 2437-2444, 2019
272019
Ceftriaxone-associated nephrolithiasis and gallstone in adults
G Azarkar, MM Birjand, A Ehsanbakhsh, B Bijari, MR Abedini, M Ziaee
Drug, healthcare and patient safety, 103-108, 2018
202018
Key regulatory miRNAs and their interplay with mechanosensing and mechanotransduction signaling pathways in breast cancer progression
H Najminejad, B Farhadihosseinabadi, M Dabaghian, A Dezhkam, ...
Molecular Cancer Research 18 (8), 1113-1128, 2020
92020
Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran
A Vazin, M Mahi Birjand, M Darake
Drug, Healthcare and Patient Safety, 21-26, 2018
82018
Investigating the sequential patterns of methamphetamine use initiation in Iran
EM Sarani, J Ahmadi, B Oji, M Mahi-Birjand, N Bagheri, A Bazrafshan, ...
Substance Abuse Treatment, Prevention, and Policy 15, 1-10, 2020
72020
Protective effects of silymarin on gentamicin-induced nephrotoxicity in infectious patients: a randomized double blinded placebo-controlled clinical trial
M Mahi-Birjand, I Karimzadeh, A Zarban, M Abdollahpour-Alitappeh, ...
Pharmaceutical Sciences 26 (3), 287-295, 2020
62020
Evaluation of vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines
M Mahi-Birjand, M Ziaee, B Bijari, R Khalvati, MR Abedini, ...
Drug, Healthcare and Patient Safety, 29-35, 2019
52019
Performance of drug and poison information center within a Referral University hospital in southwest of Iran
I Karimzadeh, A Vazin, N Talebnia, N Hatami-Mazinani, M Mahi-Birjand
Journal of Pharmaceutical Care, 49-55, 2017
42017
Comparison of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration alone in reducing amphotericin B nephrotoxicity: a …
I Karimzadeh, A Sepehr-Sobhani, MJ Khoshnoud, MM Sagheb, R Vejdani, ...
Research in Pharmaceutical Sciences 15 (6), 583-591, 2020
32020
Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran
L Zarei, N Moradi, F Peiravian, N Hatami-Mazinani, M Mahi-Birjand, ...
International Journal for Equity in Health 21 (1), 188, 2022
12022
Assessing the performance of community pharmacies in Iran by measuring responsiveness to non-medical needs: An application of WHO responsiveness framework
S Afifi, AHA Bahmani, L Zarei, M Mahi-Birjand, M Hoorang, M Zare, ...
Journal of research in pharmacy practice 10 (2), 59-64, 2021
12021
Aminoglycosides: Single-or Multiple-daily Dosing? An Updated Qualitative Systematic Review of Randomized Trials on Toxicity and Efficacy
I Karimzadeh, M Abdollahpour-Alitappeh, S Ghaffari, M Mahi-Birjand, ...
Current Molecular Medicine, 2024
2024
Compliance with Antibiotics Prophylaxis Guideline in Surgical Patients in ICUs of a Teaching Referral Hospital
A Vazin, N Hatami-Mazinani, E Alemzadeh, F Dehghani, M Mahi-Birjand
Health Services Insights 15, 11786329221136437, 2022
2022
Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland: Management and Pharmacotherapy of COVID-19 in Iran and Switzerland
P Peymani, S Bazdar, L Zarei, M Hoorang, N Hatami-Mazinani, ...
Novelty in Biomedicine 10 (4), 219-225, 2022
2022
Cover Image, Volume 235, Number 1, January 2020
S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ...
Journal of Cellular Physiology 235 (1), i-i, 2020
2020
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–18